VA innovation chief sets five-year ambition for turning ideas into veterans’ care

Beth Ripley outlined priorities in bioprinting, AI and workforce development, and described how a digitally designed denture helped a veteran who had struggled with fit for two decades.

Author
HDM Staff
Save
Share
Illuminated HLTH lettering and event entrance arch
Event branding at the entrance to HLTH USA 2026 in Las Vegas. Photo credit: HLTH USA 2026

    The Veterans Health Administration’s innovation leadership wants to shorten the route from a promising idea to use in veterans’ care, with a five-year ambition shaping its next phase of work, Beth Ripley said Wednesday. She described bringing customer input, regulatory planning and deployment decisions into development early, alongside the work of making a technology function.

    “We want five years,” Ripley said, contrasting that aspiration with the lengthy translation timelines often cited in healthcare. She presented it as a direction for innovation work over the next three years, giving no new portfolio-wide performance measure, budget or binding deadline for every project. Her emphasis was on putting development activities together so useful products can reach veterans sooner.

    Ripley spoke with host Ian Khan in The Future of Innovation with the U.S. Department of Veterans Affairs, the closing conversation at The Futurist Physical AI Summit during HLTH USA 2026 in Las Vegas. She is acting chief officer of VHA’s Office of Healthcare Innovation and Learning. The VA’s profile also describes her work leading the department’s 3D-printing network and collaborating on personalized healthcare technologies.

    A practical example from complex dental care

    Asked about a veteran whose care had changed because of the work, Ripley described a patient who had been unable to obtain dentures that fit for more than 20 years. She said a team used scans of his face to design a customized denture digitally, tried the fit and provided it to him. She described his happiness at being able to smile and his joke about becoming a movie star.

    The account put a specific clinical need behind the manufacturing discussion. Ripley described patients with difficult anatomy after injuries, cancer or other changes that can make conventional dental treatment challenging. In the example she gave, the design task was to produce a fit the patient had not been able to obtain through the usual route.

    Ripley described the department’s approach as “make what we cannot buy.” She was explaining why an organization that purchases large amounts of equipment and services also needs a way to develop certain patient-specific products. The anecdote concerned one person’s experience, and she did not present it as a comparative study or give a new system-wide estimate of cost or clinical benefit.

    The VA Puget Sound account of its X_Labs work separately describes personalized dental devices produced through digital workflows and 3D printing. It also describes work on radiation-therapy tools and patient-specific clinical planning. Those examples show several different uses of local manufacturing, each requiring evidence appropriate to what the product will do and how it will be used.

    Bioprinting brings a different development task

    Ripley identified bioprinting as one of the areas the department intends to keep pursuing, including work on bone. She said the ambition extends to platforms that could operate at more hospitals, with a focus on getting useful innovations to veterans across the network. A workable platform would need to include the processes around production as well as the equipment itself.

    VA Puget Sound opened an expanded bioprinting facility in June 2025 and described BioBone as a patient-derived bone-graft development project. That announcement provides background for the interest Ripley expressed Wednesday. Her conference remarks supplied no new clinical trial result or authorization showing that printed bone grafts are ready for routine use throughout the VA.

    The distinction matters for the five-year ambition. Producing a personalized dental device and developing a living-tissue product involve different scientific, manufacturing and clinical questions. Ripley’s roadmap encompassed both established manufacturing capabilities and areas that still need development, with the intended patient benefit guiding what the organization pursues.

    People are part of the technology plan

    Ripley also identified digital and physical AI among the VA’s interests and paired them with workforce development. “None of us learned this in school,” she said, asking how staff can acquire the capabilities needed as the technologies enter care. The comment put training alongside product development in the work required to reach veterans.

    A new tool can change who collects information, reviews its output, supports the equipment or explains the result to a patient. Those responsibilities need people with the time and preparation to carry them out. Ripley’s emphasis on the workforce suggested that accelerating a project requires attention to the eventual operating team during development, while leaving the training requirements to be established for individual products.

    She also described frontline staff as innovators with ideas drawn from the care they provide. That gives the VA a source of problems to investigate and people who can evaluate whether a proposed answer fits the work. Bringing those staff into development early can expose requirements that a team working away from the care setting would otherwise learn later.

    How outside companies can engage

    Khan asked where a company should start if it wants to work with the VA. Ripley pointed to calls to industry, including requests for information and requests for proposals, as a useful signal that the organization has gathered needs and customer requirements. She said those efforts can also include an industry day, giving companies a way to understand the problem being examined.

    Ripley said the department also wants to hear about work outside an active call, while acknowledging that it may be unable to take it up immediately. The distinction is between learning what an innovator can offer and having a current need and process through which to pursue it. Her comments announced no new procurement opportunity or award during the conversation.

    The VA’s PathFinder portal reflects that range of readiness. It provides a collaboration route for ideas that need co-development or refinement and a vendor route for products or services ready for procurement. For an outside company, the stage of the product therefore affects the kind of engagement available. The portal also notes that VA acquires products and services at national, regional and local levels, giving companies another dimension to consider when identifying where their work could meet an existing need.

    Ripley’s dental example and her longer-term interests share a test of whether the work changes something for the person receiving care. The five-year ambition brings attention to the time between identifying that need and delivering a usable response. Her closing message was that the customer, the development team and the people responsible for adoption need to be part of that effort from the beginning.